Adicet Bio Inc

ACETNASDAQ · USD
8.49USD-0.66 (-7.17%)
555

Adicet Bio Inc (ACET) Option Chain

As of September 22, 2026, Adicet Bio Inc is trading at $8.49, a -7.17% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 167.4%. IV Rank is 35%.

Read more

Tracking the ACET option chain helps you see every strike and expiry on Adicet Bio Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Adicet Bio Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of ACET options activity at a glance. Use our scanner to monitor the ACET option chain in real time and filter for the ACET options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For ACET stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the ACET option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where ACET stock options are being actively traded and where they are not.

Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and enhance persistence for durable activity in patients. Its lead product in pipeline includes ADI-001, which is in Phase I clinical study for the treatment of non-Hodgkin's lymphoma. The company also engages in the development of ADI-002, which is undergoing preclinical studies for the treatment of various solid tumors.

Adicet Bio, Inc. is based in Boston, Massachusetts.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Adicet Bio Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen ACET options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of ACET stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile50.00% Neutral
  • Market cap (M$)86
  • 52 weeks high-47.59%
  • 52 weeks low52.08%
  • Analyst recommendationStrong Buy
    1.00
  • Target price$33.17
    290.69% above the current stock price
  • Dividend
  • Payout ratio
  • Earnings date2026-11-04
  • P/E
  • Future P/E
  • EPS (ttm)-11.53
  • EPS growth next 5 years63.24%

As of September 22, 2026

2026-10-16
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
0.23000.765.994.708.802.50-72.650.250.000.250099.77
11.381000.843.492.356.305.00-45.300.950.000.950188.62
39.891301.660.991.004.307.50-17.940.051.450.000.7523260.11
66.205811.650.001.6510.00+9.411.202.851.510.5210420033.80
82.672231.180.000.401.9512.50+36.761.605.704.01-0.360017.33

As of September 22, 2026

Scan the full option chain in one place

Browse the full ACET option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.

Start your 14-day free trial